[{"NetIncomeLoss_3_Q3_USD":-101444000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":197000.0,"ConstructionInProgressGross_0_Q3_USD":44200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":8604737.0,"Depreciation_1_Q3_USD":800000.0,"Depreciation_3_Q3_USD":1900000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-534354000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":124000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":265567000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":1.67,"CommitmentsAndContingencies_0_Q3_USD":null,"GeneralAndAdministrativeExpense_1_Q3_USD":13960000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":37134000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":1.69,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q3_USD":10104000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-104000.0,"MarketableSecuritiesCurrent_0_Q3_USD":494958000.0,"AssetsCurrent_0_Q3_USD":523087000.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":0.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"ContractualObligation_0_Q3_USD":78700000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":2.92,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":10547900.0,"ShareBasedCompensation_3_Q3_USD":17293000.0,"Assets_0_Q3_USD":647397000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":699987000.0,"CommonStockSharesIssued_0_Q3_shares":128857283.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-18000.0,"LeaseAndRentalExpense_1_Q3_USD":600000.0,"LeaseAndRentalExpense_3_Q3_USD":1800000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":121000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":19840732.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-18000.0,"DeferredCosts_0_Q3_USD":0.0,"ConstructionPayableCurrent_0_Q3_USD":11178000.0,"Liabilities_0_Q3_USD":45977000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-658000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-1021000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":128794142.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":98256027.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":10000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-128000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":2352000.0,"TemporaryEquityLiquidationPreference_0_Q3_USD":0.0,"EarningsPerShareBasic_1_Q3_USD":-0.33,"EarningsPerShareBasic_3_Q3_USD":-1.03,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":4.65,"ResearchAndDevelopmentExpense_1_Q3_USD":29064000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":64674000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":3160000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":205000000.0,"GrantsReceivableCurrent_0_Q3_USD":861000.0,"CommonStockValue_0_Q3_USD":0.0,"OtherReceivablesNetCurrent_0_Q3_USD":484000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":20400000.0,"OtherAssetsNoncurrent_0_Q3_USD":4794000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":0.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3750000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-42899000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-101265000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":597000.0,"OtherAssetsCurrent_0_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_3_Q3_USD":130000.0,"RestrictedCash_0_Q3_USD":500000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":130000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":392966000.0,"TemporaryEquitySharesIssued_0_Q3_shares":0.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-602000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":1859000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":11.57,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2877000.0,"AccrualForTaxesOtherThanIncomeTaxesCurrent_0_Q3_USD":436000.0,"AccountsPayableCurrent_0_Q3_USD":5254000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-220736000.0,"LiabilitiesCurrent_0_Q3_USD":32087000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":1529000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":128794142.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":98256027.0,"NonoperatingIncomeExpense_3_Q3_USD":-657000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-79348000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":8726000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-43663000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-102465000.0,"Goodwill_0_Q3_USD":5722000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q3_USD":2200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q3_shares":12854437.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3_Q3_shares":8660000.0,"NonoperatingIncomeExpense_1_Q3_USD":-639000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":20900000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7729000.0,"NetIncomeLoss_1_Q3_USD":-43005000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":103690000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":68914000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-69000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":10878000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":52460000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":12690000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":1475000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":3820528.0,"AdditionalPaidInCapital_0_Q3_USD":747891000.0,"StockIssued1_3_Q3_USD":0.0,"SecurityDeposit_0_Q3_USD":111000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":70960000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1559000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":106000.0,"ConversionOfStockAmountConverted1_3_Q3_USD":384426000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":2087000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":4369857.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":17293000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":9157000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":647397000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":0.41,"DeferredRentReceivablesNetNoncurrent_0_Q3_USD":2088000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":9.57,"AllocatedShareBasedCompensationExpense_1_Q3_USD":8734000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q3_USD":12407000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":10547900.0,"OperatingIncomeLoss_1_Q3_USD":-43024000.0,"OperatingIncomeLoss_3_Q3_USD":-101808000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":0.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":339016000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_3_Q3_pure":0.05,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":68700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":275400.0,"RestrictedCashNoncurrent_0_Q3_USD":500000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.33,"EarningsPerShareDiluted_3_Q3_USD":-1.03,"CommonStockSharesOutstanding_0_Q3_shares":128857283.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-146367000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":4249857.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":19840732.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-12000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":39367000.0,"StockholdersEquity_0_Q3_USD":601420000.0,"OtherLiabilitiesCurrent_0_Q3_USD":234000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1537000.0,"OperatingExpenses_1_Q3_USD":43024000.0,"OperatingExpenses_3_Q3_USD":101808000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":105777000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":2469000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":10800000.0,"Ticker":"TIL","CIK":"1789769","name":"INSTIL BIO, INC.","OfficialName":"Instil Bio Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"1149731379.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211115"}]